Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Rite Aid

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

StockNews.com

Clock ticking for West Virginia to select leadership for opioid money distribution

West Virginia is finalizing the leadership for a newly created foundation tasked with distributing the lion’s share of the more than $1 billion in opioid lawsuit-settlement money

The Independent UK

West Virginia settles with Kroger, opioid money now tops $1B

West Virginia has settled with Kroger for $68 million over its role in distributing highly addictive prescription painkillers into the U.S. state that has lost more lives to opioid overdoses per capita than any other

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Justice Department sues Rite Aid for hundreds of thousands of ‘unlawful’ prescriptions at height of opioid crisis

The Justice Department accused the pharmacy giant of ignoring red flags when prescribing opioids

The Independent UK

US sues Rite Aid for allegedly missing ‘red flags’ in unlawful prescriptions

DoJ alleges pharmacy chain knowingly filled prescriptions that were ‘medically unnecessary’, including opioids

The Guardian - US

U.S. government lawsuit accuses Rite Aid of unlawful opioid prescriptions

The DOJ alleges prescriptions were filled despite clear "red flags."

Axios

Rite Aid Shares Jumped 40% Last Week - Buy, Sell, Hold?

Rite Aid (RAD) shares soared last week after the company reported stronger-than-expected first-quarter revenue growth and issued an upbeat sales forecast. However, given the company’s increasing losses and projected interest rate hikes, is it worth buying the stock now? Let’s find out.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Amazon, Rite Aid cap purchase of emergency contraceptives

Amazon is limiting how many emergency contraceptives consumers can buy, joining other retailers who put in place similar caps following the Supreme Court decision overruling Roe v. Wade

The Independent UK

US pharmacies reportedly set purchase limit on emergency contraception pills

Walmart, CVS and Rite Aid – as well as Amazon – have all set caps on the number of morning-after pills people can purchase

The Guardian - US

Effect Of Roe Vs. Wade Ruling - Pharmacies Ration Contraceptive Pills

Major pharmacies like CVS Health Corp (NYSE:CVS), Walmart Inc (NYSE:WMT), and Rite Aid Corporation (NYSE:RAD) have put a limit on purchases or deliveries of Plan B and other emergency contraceptive pills, writes Wall Street Journal. The move comes as demand for contraceptive pills spiked following the Supreme Court ruling overturning a constitutional right to abortion. These were in…

Benzinga

Rite Aid Shares Jump After Upbeat Annual Guidance

Rite Aid Corp (NYSE:RAD) has reported Q1 FY23 sales of 6.01 billion, down 2.4% Y/Y, beating the consensus of $5.75 billion. The company reported an EPS loss of $(0.60) compared to an income of $0.38 a year ago, driven by non-cash impairment charges and cycling prior-year COVID vaccination benefit. Retail Pharmacy Segment…

Benzinga

Why Rite Aid Stock Is Rising Today

Rite Aid Corp (NYSE: RAD) shares are trading higher Thursday after the company announced better-than-expected financial results and raised full-year revenue guidance above analyst estimates.

Benzinga

Rite Aid: Q1 Earnings Insights

Rite Aid (NYSE:RAD) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Earnings Outlook For Rite Aid

Rite Aid (NYSE:RAD) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that Rite Aid will report an earnings per share (EPS) of $-0.70.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyzing Rite Aid's Short Interest

Rite Aid's (NYSE:RAD) short percent of float has risen 7.6% since its last report. The company recently reported that it has 18.53 million shares sold short, which is 34.26% of all regular shares that are available for trading.

Benzinga

What Caused Rite Aid Stock To Spike Today?

Rite Aid Corp (NYSE: RAD) shares closed Wednesday's regular session up more than 11% following a report suggesting the company rejected an $815 million takeover bid earlier this month.

StockNews.com

Is Rite Aid Stock a Buy After Reporting Strong Q4 Results?

Leading pharmaceutical retailer Rite Aid (RAD) shares jumped last week thanks to its stronger-than-expected fourth-quarter revenue growth driven by an increase in same-store and pharmacy sales. Although the company’s strategic initiatives to boost membership should bode well for the stock, its struggling Elixir business and expanding losses could lead to…

Benzinga

Recap: Rite Aid Q4 Earnings

Rite Aid (NYSE:RAD) reported its Q4 earnings results on Thursday, April 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Rite Aid missed estimated earnings by 191.07%, reporting an EPS of $-1.63 versus an estimate of $-0.56.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Rite Aid Shares Are Soaring Today

Rite Aid Corp (NYSE:RAD) has reported Q4 FY22 sales of 6.06 billion, +2.5% Y/Y, beating the consensus of $5.95 billion. The Company reported an EPS loss of $(1.63) compared to $(0.78) a year ago. The growth is driven by growth in the Retail Pharmacy, partially offset by a decline in the Pharmacy…

Benzinga

Earnings Outlook For Rite Aid

Rite Aid (NYSE:RAD) is set to give its latest quarterly earnings report on Thursday, 2022-04-14. Here's what investors need to know before the announcement. Analysts estimate that Rite Aid will report an earnings per share (EPS) of $-0.56.

Benzinga

Rite Aid Earnings Conference Call Is Coming Up, Here's What You Need To Know

Rite Aid (NYSE:RAD) will host a conference call at 08:30 AM ET on April 14, 2022, to discuss Q4 2022 earnings results. How to Attend Rite Aid (RAD) Conference Call Follow this link to access the live webcast.

Benzinga

Thinking About Buying Stock Or Options In Wells Fargo, Taiwan Semiconductor Manufacturing Or Rite Aid?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers, and following industry trends.

Benzinga

PreMarket Prep Stock Of The Day: What's Ailing Rite Aid?

It is a rarity when Wall Street analysts come out with a “sell” rating on a company. Yet in this market environment, when it occurs, it has a notable impact on the company being targeted.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Upgrades

Benzinga

Deutsche Bank Sees Potential 'Dramatic Negative Inflection Point' For Rite Aid

Ahead of the Company's fiscal Q4 results on April 14, Deutsche Bank downgraded Rite Aid Corporation (NYSE:RAD) to Sell from Hold with a price target of $1, down from $16. Analyst George Hill believes COVID has "hastened the decline" for the Company, and he sees the potential for a "dramatic negative inflection point"…

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.